Epidemiology of primary biliary cholangitis in Italy: Evidence from a real-world database |
Author(s): Marzioni M1, Bassanelli C2, Ripellino C3, Urbinati D3, Alvaro D4 |
Affiliations(s): 1 Clinic of Gastroenterology and Hepatology, Università Politecnica delle Marche, Ancona, Italy 2 Intercept Italia srl, Milan, Italy 3 IQVIA, Milan, Italy 4 Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy |
Publication(s): Dig Liver Dis. 2019 May;51(5):724-729
|
Document Type(s): Article, |
Countries: Italy, |
C: Y: |
Gastrointestinal disorders, 2019 |
|
L: A: |
English Database Study, Epidemiological study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis, |
|
|
|
|
Cost of inflammatory bowel disease management in the kingdom of Saudi Arabia |
Author(s): Al Jedai A1, AL-Mudaiheem H1, Haines A2, Mosli M3, Albogami M4, Al-jaroudi F5, Alsaqa'aby M6, Awad N7, Mohamed O8 |
Affiliations(s): 1Ministry of Health, Riyadh, NJ, USA, 2Toronto University, Toronto, ON, Canada, 3King Abdulaziz University, Jeddah, Saudi Arabia, 4Ministry of Health, Damam, Saudi Arabia, 5King Fahad Specialist Hospital, Damam, Saudi Arabia, 6King Faisal Specialized Hospital and Research Center, Riyadh, Saudi Arabia, 7IQVIA, Dubai, United Arab Emirates, 8IQVIA, Dubai, DU, United Arab Emirates |
Publication(s): 2019-11, ISPOR Europe 2019, Copenhagen, Denmark
|
Document Type(s): Poster, |
Countries: Saudi Arabia, |
Click here for the abstract |
C: Y: |
Gastrointestinal disorders, 2019 |
|
L: A: |
English Budget impact, Literature Review, |
|
|
|
|
Severe intestinal malabsorption associated with ACE inhibitor or angiotensin receptor blocker treatment. An observational cohort study in Germany and Italy |
Author(s): Malfertheiner P1, Ripellino C2, Cataldo N3 |
Affiliations(s): 1 Klinik für Gastroenterologie, Hepatologie und Infektiologie, Otto-von-Guericke Universität, Magdeburg, Germany 2 2HEOR Consultant Freelance, Milan, Italy 3 IQVIA, RWI, Milan, Italy |
Publication(s): Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):581-586
|
Document Type(s): Article, |
Countries: Germany, Italy, |
Click here for the abstract |
C: Y: |
Gastrointestinal disorders, 2018 |
|
L: A: |
English Database Study, Epidemiological study, Observational study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis, |
|
|
|
|
5-ASA Prescription Trends over Time in Inflammatory Bowel Disease 1996 to 2015-A UK Population-Based Study
|
Author(s): Jaraith, V, S Hokkanen, L Guizzetti, N Boxall, S Campbell-Hill, and H Patel
|
Affiliations(s): Western University, Department of Medicine, London, Ontario, Canada, Robarts Clinical Trials Inc., London, Ontario, Canada, IQVIA, London, UK,
|
Publication(s): Journal of Crohn, no. Supplement 1 (February): S309–10
|
Document Type(s): Abstract, |
Countries: UK, |
Click here for the abstract |
C: Y: |
Clinical practice, Drug Utlization Study, Gastrointestinal disorders, 2018 |
|
L: A: |
English Epidemiological study, Retrospective cohort analysis, |
|
|
|
|
Time Between Suspected and Confirmed Diagnosis of Crohn's Disease and Ulcerative Colitis in Patients Followed in Gastroenterological Practices in Germany |
Author(s): Jacob K, Konrad M, Kostev K |
Affiliations(s): |
Publication(s): INT J COLORECTAL DIS. 2018 MAY
|
Document Type(s): Article, |
Countries: Germany, |
C: Y: |
Gastrointestinal disorders, 2018 |
|
L: A: |
English
|
|
|
|
|
5-ASA prescription trends over time in inflammatory bowel disease 1996-2015 – a UK population-based study
|
Author(s): Vipul Jairath (1,2), Suvi Hokkanen (3), Leonardo Guizzetti (2), Naomi Boxall (3), Sarah Campbell-Hill (4), Haridarshan Patel (4)
|
Affiliations(s): (1) Department of Medicine, Western University, London Ontario, Canada; (2) Robarts Clinical Trials Inc., London Ontario, Canada; (3) IQVIA, London, UK; (4) Takeda International – UK Branch, London, UK
|
Publication(s): |
Document Type(s): Poster, |
Countries: |
C: Y: |
Gastrointestinal disorders, 2018 |
|
L: A: |
English Population Based Study, |
|
|
|
|
Impact of adalimumab’s patient support program on clinical outcomes
in inflammatory bowel diseases: Results from the COMPANION study |
Author(s): Marshall JK1, Narula N1, Millson B2, Charland K2, Sung M2, Gaetano T3, McHugh K3, Latour M3, Laliberté MC3 |
Affiliations(s): |
Publication(s): European Crohn’s and Colitis Organization 2017 Conference, February 15-18, Barcelona, Spain
|
Document Type(s): Poster, |
Countries: Canada, |
C: Y: |
Gastrointestinal disorders, 2017 |
|
L: A: |
English Retrospective database analysis, |
|
|
|
|
Canadian Study of Adherence Outcomes in HUMIRA® (Adalimumab) Patients: Three-Year Results from the COMPANION Study in Gastroenterology Patients |
Author(s): Marshall JK1, Millson B2, Sung M2, Gaetano T3, Latour M3, Laliberté MC3 |
Affiliations(s): 1 Department of Medicine, Division of Gastroenterology, Farncombe Family Digestive Health Research Institute; McMaster University, Hamilton, Ontario, Canada 2 IMS Brogan, Kirkland, Quebec, Canada 3 AbbVie Corporation, St. Laurent, Quebec, Canada |
Publication(s): Canadian Digestive Diseases Week 2017 Annual Scientific Conference, March 3-6, Banff, Canada
|
Document Type(s): Poster, |
Countries: Canada, |
Click here for the abstract |
C: Y: |
Gastrointestinal disorders, 2017 |
|
L: A: |
English Database Study, |
|
|
|
|
Patient adherence to subcutaneous IFN beta-1a injections using the RebiSmart® injection device: a retrospective real-world study among Dutch and German patients with multiple sclerosis |
Author(s): Marieke Krol1, Gert de Voer2, Ulrike Osowski3 |
Affiliations(s): 1QuintilesIMS, Capelle aan den Ijssel, the Netherlands; 2Merck B.V., Schiphol-Rijk, the Netherlands; 3Merck KGaA, Darmstadt, Germany |
Publication(s): Patient Preference and Adherence 2017:11 1189–1196
|
Document Type(s): Article, |
Countries: Germany, Netherlands, |
C: Y: |
Gastrointestinal disorders, 2017 |
|
L: A: |
English Retrospective cohort analysis, Retrospective database analysis, |
|
|
|
|
Unspecified intestinal malabsorption in patients treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers: a retrospective analysis in primary care settings |
Author(s): De Bortoli N1, Ripellino C2, Cataldo N3, Marchi S1 |
Affiliations(s): 1 Gastroenterology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy
2 Department of Real World Evidence, HEOR Consultant Freelance, Milan, Italy
3 Department of Real World Evidence, QuintilesIMS, Milan, Italy |
Publication(s): Expert Opinion on Drug Safety.
doi: 10.1080/14740338.2017.1376647. [Epub ahead of print]
|
Document Type(s): Article, |
Countries: Germany, Italy, |
Click here for the abstract |
C: Y: |
Drug safety, Gastrointestinal disorders, Rare Diseases, 2017 |
|
L: A: |
English Clinical setting: Primary care, Database Study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis, |
|
|
|
|
1 of 11
|